This Big Pharma Stock Is a Clear Buy
The pharmaceutical industry is one of the steadiest in the world (even with the risks of patent expirations that come with it). After all, millions of patients around the world rely on the industry and its essential medicines.
New York-based Bristol-Myers Squibb (NYSE: BMY) is among the largest pharmaceutical companies in the world. And its stock is a no-brainer buy for investors seeking reliable dividend income. Here are four reasons why.
Bristol-Myers' $151 billion market capitalization positions it as the eighth-biggest drugmaker on the planet. As you would expect from a company of its size, the pharmaceutical company possesses a strong portfolio of prescription-based and non-prescription medicines.
Source Fool.com
